Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Market Cap Dropped CN¥588m Last Week; Individual Investors Bore the Brunt
Shinva Medical Instrument Co.,Ltd.'s (SHSE:600587) Market Cap Dropped CN¥588m Last Week; Individual Investors Bore the Brunt
Key Insights
主要見解
- Shinva Medical InstrumentLtd's significant individual investors ownership suggests that the key decisions are influenced by shareholders from the larger public
- The top 14 shareholders own 50% of the company
- 23% of Shinva Medical InstrumentLtd is held by Institutions
- 新華醫療重要的個人投資者持股情況表明,關鍵決策受到較大公衆股東的影響。
- 前14名股東持有該公司50%的股權。
- 新華醫療有23%的股份由機構持有。
Every investor in Shinva Medical Instrument Co.,Ltd. (SHSE:600587) should be aware of the most powerful shareholder groups. With 43% stake, individual investors possess the maximum shares in the company. That is, the group stands to benefit the most if the stock rises (or lose the most if there is a downturn).
對於新華醫療股票(SHSE:600587)的每個投資者來說,都應該了解最大的股東群體。目前個人投資者持有43%的股份,這意味着如果股價上漲,該群體將獲益最多(或者如果存在下跌,將虧損最多)。
As market cap fell to CN¥9.3b last week, individual investors would have faced the highest losses than any other shareholder groups of the company.
隨着市值上週下降到93億人民幣,個人投資者將面臨公司股東中最高的損失。
In the chart below, we zoom in on the different ownership groups of Shinva Medical InstrumentLtd.
在下面的圖表中,我們將放大新華醫療的不同所有權集團。
What Does The Institutional Ownership Tell Us About Shinva Medical InstrumentLtd?
機構所有權告訴我們有關新華醫療的什麼?
Many institutions measure their performance against an index that approximates the local market. So they usually pay more attention to companies that are included in major indices.
許多機構衡量其業績的標準是一個近似於當地市場的指數。因此,他們通常更加關注包括在主要指數中的公司。
As you can see, institutional investors have a fair amount of stake in Shinva Medical InstrumentLtd. This suggests some credibility amongst professional investors. But we can't rely on that fact alone since institutions make bad investments sometimes, just like everyone does. When multiple institutions own a stock, there's always a risk that they are in a 'crowded trade'. When such a trade goes wrong, multiple parties may compete to sell stock fast. This risk is higher in a company without a history of growth. You can see Shinva Medical InstrumentLtd's historic earnings and revenue below, but keep in mind there's always more to the story.
如您所見,機構投資者在新華醫療中擁有相當大的股份。這表明在專業投資者中有一定的信譽。但我們不能僅僅依靠這一事實,因爲機構有時也會做出糟糕的投資,就像其他人一樣。當多家機構持有一支股票時,總有一種風險,即它們是在一種「擁擠的交易」中。當這種交易出現問題時,多方可能會競相快速出售股票。在沒有增長曆史的公司中,這種風險更高。您可以在下面看到新華醫療的歷史收入和營業收入,但請記住故事總是更多。
We note that hedge funds don't have a meaningful investment in Shinva Medical InstrumentLtd. Looking at our data, we can see that the largest shareholder is Shandong Energy Group Co., Ltd. with 29% of shares outstanding. Meanwhile, the second and third largest shareholders, hold 4.1% and 3.9%, of the shares outstanding, respectively.
我們注意到對沖基金在新華醫療設備有着不多的投資。根據我們的數據,最大的股東是山東能源集團有限公司,持有29%的股份。同時,第二和第三大股東分別持有4.1%和3.9%的股份。
After doing some more digging, we found that the top 14 have the combined ownership of 50% in the company, suggesting that no single shareholder has significant control over the company.
經過更深入的挖掘,我們發現前14名股東合計持有該公司的50%股權,表明沒有單一股東對該公司有重大控制權。
While studying institutional ownership for a company can add value to your research, it is also a good practice to research analyst recommendations to get a deeper understand of a stock's expected performance. There is some analyst coverage of the stock, but it could still become more well known, with time.
雖然研究公司的機構持股可以增加研究價值,但研究分析師建議以更深入地了解股票的預期表現也是一個好習慣。該股票的一些分析人士需要更多的關注時間。
Insider Ownership Of Shinva Medical InstrumentLtd
新華醫療設備有限公司的內部所有權
While the precise definition of an insider can be subjective, almost everyone considers board members to be insiders. Management ultimately answers to the board. However, it is not uncommon for managers to be executive board members, especially if they are a founder or the CEO.
雖然內部人員的精確定義可能具有主觀性,但幾乎所有人都認爲董事會成員是內部人員。管理層最終向董事會負責。然而,如果經理是創始人或CEO,那麼他們成爲執行董事會成員並不罕見。
I generally consider insider ownership to be a good thing. However, on some occasions it makes it more difficult for other shareholders to hold the board accountable for decisions.
我通常認爲內部人士持股是一件好事。但是,在某些情況下,它會使其他股東更難以對董事會的決定進行問責。
Our information suggests that Shinva Medical Instrument Co.,Ltd. insiders own under 1% of the company. But they may have an indirect interest through a corporate structure that we haven't picked up on. Keep in mind that it's a big company, and the insiders own CN¥24m worth of shares. The absolute value might be more important than the proportional share. It is always good to see at least some insider ownership, but it might be worth checking if those insiders have been selling.
我們的信息顯示,新華醫療儀器股份有限公司的內部持股不到公司的1%。但通過我們還沒有了解到的公司架構,他們可能間接擁有利益。請記住,這是一家大公司,內部持股價值爲2400萬元人民幣。絕對值可能比比例份額更重要。看到至少有部分內部持股總是好的,但可能值得檢查一下這些內部人士是否一直在拋售。
General Public Ownership
一般大衆所有權
The general public, who are usually individual investors, hold a 43% stake in Shinva Medical InstrumentLtd. While this group can't necessarily call the shots, it can certainly have a real influence on how the company is run.
普通公衆,通常是個人投資者,持有新華醫療儀器有限公司43%的股份。儘管這個群體不一定能決定事情的走向,但肯定會對公司的運營產生真正的影響。
Private Company Ownership
私有公司的所有權
Our data indicates that Private Companies hold 34%, of the company's shares. It might be worth looking deeper into this. If related parties, such as insiders, have an interest in one of these private companies, that should be disclosed in the annual report. Private companies may also have a strategic interest in the company.
我們的數據表明,私營企業持有公司股份的34%。深入了解這一點可能是值得的。如果相關方,例如內部人員,在這些私營公司之一擁有利益,則應在年度報告中披露。私營公司也可能對公司具有戰略性利益。
Next Steps:
下一步:
It's always worth thinking about the different groups who own shares in a company. But to understand Shinva Medical InstrumentLtd better, we need to consider many other factors. Take risks for example - Shinva Medical InstrumentLtd has 1 warning sign we think you should be aware of.
始終值得考慮有多個股份的公司的不同群體。但是要更好地了解新華醫療,我們需要考慮許多其他因素。以風險爲例——新華醫療有一個我們認爲您應該注意的風險警示指數。
Ultimately the future is most important. You can access this free report on analyst forecasts for the company.
最終,未來最重要。您可以在這份關於該公司分析師預測的免費報告中獲取有關信息。
NB: Figures in this article are calculated using data from the last twelve months, which refer to the 12-month period ending on the last date of the month the financial statement is dated. This may not be consistent with full year annual report figures.
注:本文中的數據是使用最後一個財務報表日期結束的爲期12個月的數據計算的。這可能與全年年度報告數據不一致。
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
對本文有任何反饋?對內容有任何疑慮?請直接與我們聯繫。或者,發送電子郵件至editorial-team@simplywallst.com。
這篇文章是Simply Wall St的一般性文章。我們根據歷史數據和分析師預測提供評論,只使用公正的方法論,我們的文章並不意味着提供任何金融建議。文章不構成買賣任何股票的建議,也不考慮您的目標或您的財務狀況。我們的目標是帶給您基本數據驅動的長期關注分析。請注意,我們的分析可能不考慮最新的價格敏感公司公告或定性材料。Simply Wall St沒有任何股票頭寸。